Radiocontrast media-induced nephrotoxicity in patients with renal failure: rationale for a new double-blind, prospective, randomized trial testing calcium channel antagonists.
Esnault
Vincent L M
VL
Service de Néphrologie-Immunologie Clinique, CHU Hôtel Dieu, Nantes, France. vesnault@nantes.inserm.fr
D002121:Calcium Channel Blockers; D003287:Contrast Media / Q000009:adverse effects*; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000473:pathology*; D011859:Radiography; D019275:Radiopharmaceuticals / Q000009:adverse effects*; D016032:Randomized Controlled Trials as Topic; D051437:Renal Insufficiency / Q000000981:diagnostic imaging*
D002121:Calcium Channel Blockers; D003287:Contrast Media; D019275:Radiopharmaceuticals